Business
Heidelberg Pharma Announces Changes to the Executive Management Board - Dr Dongzhou Jeffery Liu Appointed as Chairman of the Executive Board and Chief Executive Officer
LADENBURG, Germany - November 24, 2025 (NEWMEDIAWIRE) - Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech company developing innovative Antibody Drug Conjugates (ADCs), today announced that the Supervisory Board has revoked the appointme...
About this update from Heidelberg Pharma Ag
View the original release on www.newmediawire.com
View stock analysis, news, and events for Heidelberg Pharma Ag